478 related articles for article (PubMed ID: 28454897)
1. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Gabrielson AT; Spitz JT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
[TBL] [Abstract][Full Text] [Related]
2. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
3. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
[TBL] [Abstract][Full Text] [Related]
6. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Natale C; McLellan DM; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
[TBL] [Abstract][Full Text] [Related]
7. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
Dhillon S
Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
[TBL] [Abstract][Full Text] [Related]
9. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
[TBL] [Abstract][Full Text] [Related]
12. Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
Abdel Raheem A; Johnson M; Ralph D; Garaffa G
Minerva Urol Nefrol; 2018 Aug; 70(4):380-385. PubMed ID: 29761688
[TBL] [Abstract][Full Text] [Related]
13. Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
Masterson TA; Atuluru P; Zucker I; Molina M; Ibrahim E; Nackeeran S; Kava B; Ramasamy R
Eur Urol Focus; 2023 Jan; 9(1):55-59. PubMed ID: 36272924
[TBL] [Abstract][Full Text] [Related]
14. Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
Mills SA; Gelbard MK
World J Urol; 2020 Feb; 38(2):269-277. PubMed ID: 31168744
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
16. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
18. Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.
Anaissie J; Powers MK; Hellstrom WJ; Yafi FA
Drugs Today (Barc); 2015 Aug; 51(8):457-68. PubMed ID: 26380384
[TBL] [Abstract][Full Text] [Related]
19. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
El-Khatib FM; Towe M; Yafi FA
World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
[TBL] [Abstract][Full Text] [Related]
20. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
